Study flags need to monitor frailty risks with GLP-1 drugs for older adults - Reuters
Study flags need to monitor frailty risks with GLP-1 drugs for older adults Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
No locations linked to this story
Tags
All Coverage
<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPUU1ZX1Zfd0F3c1A5M0ZuNktDa3MzY0xMZklnTEN3cjdqam5CWWpTM2tHamp3YXhFMjVPSm43SlFweUk2R3RuS1FJa1A0WUFtSTNVUlYxWjdRb2RXSmczOW1fUDBkcTNPVWZlR29ocThIWnFpUnhCX09LYVVqLTFQc1RjRHI3WFlwYjIzVVU2aEhOa1JBRlNoV2pnVWRoTFM3YXJYYXFJcUhoYXZTd1ZpSmRwX3NKT05kM3Vqc3FR?oc=5" target="_blank">Study flags need to monitor frailty risks with GLP-1 drugs for older adults</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice - Reuters
India's Torrent Pharma recalls select semaglutide pens after Dr. Reddy's notice Reuters
July 9, 2026 at 12:23 PMGSK's Jemperli meets main goal in mid-stage rectal cancer trial - Reuters
GSK's Jemperli meets main goal in mid-stage rectal cancer trial Reuters
July 13, 2026 at 06:45 PMSouth African regulators issue recall of Ozempic copies - Reuters
South African regulators issue recall of Ozempic copies Reuters
July 9, 2026 at 09:14 PMBiogen's Alzheimer's drug lowers toxic protein, but results were mixed - Reuters
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed Reuters
July 14, 2026 at 04:17 PMFDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug - Reuters
FDA approves at-home starter dose of Eisai-Biogen Alzheimer's drug Reuters
July 13, 2026 at 08:59 PMEurope's financial stability watchdog examining private credit risks, adviser says - Reuters
Europe's financial stability watchdog examining private credit risks, adviser says Reuters
July 9, 2026 at 03:16 PM